MPX Bioceutical (CSE:MPX) announced the opening of a new dispensary location in Baltimore, Maryland.

As quoted in the press release:


The dispensay is operated by MPX’s indirect wholly-owned subsidiary, S8 Management LLC, through its  management agreement with GreenMart of Maryland, LLC (“GreenMart MD”), which is authorized to operate and sell medical cannabis products in Maryland. This is the Company’s second dispensary in Maryland, following the opening of its flagship Health for Life dispensary in Bethesda, in August 2018. Health for Life Baltimore is open to patients Sunday through Saturday.

The dispensary, which follows MPX’s southwest dispensary staples of copper accents, rustic wood paneling and navy blue walls, is set to welcome upwards of 100 patients during opening week, with trained consultants readily available to advise on all things cannabis. Maryland residents, who are approved medical cannabis patients, will have access to flower, topicals, concentrates and other forms permitted under Maryland regulations.

“The Baltimore community is no stranger to the plant, but now seeks holistic, individualized health care,” said Julie Winter, Senior Vice President of East Coast Operations, MPX. “The array of products and services offered by the Health for Life brand makes the store more than just a medical cannabis dispensary, but rather a reliable brand that patients can go to for consistent medicine and education about the plant as it becomes mainstream.”

Click here to read the full press release.

Source: globenewswire.com

The Israeli cannabis market is picking up with a new supply deal from a Canadian producer.

Also this week, new data showed sales of Canadian cannabis edible products may be stalling.

Keep reading... Show less

The Israeli cannabis market is picking up as a Canadian producer announced a new supply deal in the country.

Also this week it was shown the sales of Canadian cannabis edible products may be stalling, according to new data.

Keep reading... Show less

The Portnoy Law Firm advises investors that class action lawsuits have been filed on behalf of investors in the following publicly traded companies. Shareholders interested in taking an active role in these cases have until the deadlines indicated below to petition the court. There is no cost or obligation to you. See below for more information on these cases.

Credit Acceptance Corporation investors (NASDAQ: CACC); December 1, 2020 deadline, click here to join .

Keep reading... Show less
  • On November 19 , the Mexican Senate passed comprehensive adult-use cannabis legalization, moving Mexico towards becoming one of the few countries to legalize cannabis nationally
  • On March 31, 2020 , the Company entered into an agreement with Tecnologico de Monterrey , the leading university in Mexico , to educate physicians across Latin America , in advance of the impending regulations in Mexico
  • To date, close to 550 LatAm physicians have obtained their diploma accrediting completion of Khiron’s medical education program
  • The Company plans to deploy its ZereniaTM medical cannabis clinics and telehealth strategy in Mexico , building on the success of its vertical integration strategy in Colombia
  • Expanding the Zerenia clinic strategy will build on the Company’s Colombia knowledge and proven distribution capabilities, with rapid telehealth service adoption and over 5,600 medical cannabis scripts filled to date
  • Mexico represents one of the largest potential markets for medical cannabis in the world and is anticipated to reach $1.2bn USD by 2028 (Prohibition Partners).
  • Company to release Q3 2020 financials and host webcast on Tuesday, December 1st

Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN ), (OTCQX: KHRNF), ( Frankfurt : A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe welcomes the passing of adult-use cannabis legislation by the Mexican Senate, which moves the country closer to a legalized cannabis market, and towards provision for medical cannabis products.  Khiron has had a presence in Mexico since 2018 and has been working with doctors and medical institutions to develop a deep understanding of the market.

Keep reading... Show less

Recap of special management call includes upcoming corporate milestones and details of proposed combination with established beverage manufacturer

Emerging leader in infused cannabis beverages, BevCanna Enterprises Inc. (CSE:BEV, OTCQB:BVNNF, FSE:7BC) (“BevCanna” or the “Company”) is pleased to provide a recorded recap of the special management call held on Tuesday November 24, 2020. The call discussed upcoming corporate milestones and reviewed recent developments at the developer and manufacturer of cannabinoid‐infused beverages and consumer products for in‐house brands and white label clients.

Keep reading... Show less